The mismatch repair deficiency market is experiencing significant growth, driven by increasing awareness and adoption of genetic testing for cancer diagnostics. Rising prevalence of dMMR/MSI-H tumors and expanding indications for immunotherapies, particularly PD-1 inhibitors, are fueling...
Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight
Seeking Alpha / 23 hours ago 1 Views
Comments